Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of eszopiclone as adjunctive therapy in the treatment of
insomnia in patients with insomnia related to Generalized Anxiety Disorder. All subjects will
receive an approved anxiolytic agent and will be randomized to nightly therapy with either
eszopiclone or placebo.